CRGX News

Shareholder Alert: The Ademi Firm Continues to Investigate Whether CARGO Therapeutics, Inc. is Obtaining a Fair Price for its Public Shareholders

CRGX

(NASDAQ:CRGX) MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating CARGO (NASDAQ: CRGX) for possible breaches of fiduciary duty and other violations of law in its transaction with Concentra Biosciences. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, shareholders of CARGO will receive $4.379 in cash per share, plus one non-transferable continge

September 15, 2025Legal
Read more →

Shareholder Alert: The Ademi Firm Investigates Whether CARGO Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders

CRGX

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating CARGO (NASDAQ: CRGX) for possible breaches of fiduciary duty and other violations of law in its transaction with Concentra Biosciences. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, shareholders of CARGO will receive $4.379 in cash per share, plus one non-transferable continge

August 8, 2025Lawsuits
Read more →

CARGO Therapeutics Suspends CRG-023 & Allogeneic Platform, Initiates 90% Workforce Reduction; Anup Radhakrishnan Named Interim CEO To Explore Reverse Merger; $368.1M Cash Reserves As Of Year-End 2024

CRGX

March 18, 2025
Read more →

CARGO Therapeutics Reports 71 Patients Dosed In Phase 2 Firicabtagene Autoleucel Study; Interim Results Expected H1'25; FDA Clears IND For CRG-023, Phase 1 Enrollment Mid-2025; Announces Novel Allogeneic Platform For CAR T-Cell Therapy

CRGX

January 10, 2025
Read more →

HC Wainwright & Co. Reiterates Buy on Cargo Therapeutics, Maintains $33 Price Target

CRGX

November 15, 2024
Read more →

CARGO Therapeutics Announces ASH 2024 Abstract On CRG-023

CRGX

November 5, 2024
Read more →

Truist Securities Reiterates Buy on Cargo Therapeutics, Lowers Price Target to $32

CRGX

May 16, 2024
Read more →